Mytelase

Mytelase is a brand name for the drug ambenonium chloride, a reversible cholinesterase inhibitor used to treat symptoms of myasthenia gravis. It is manufactured by Roche.

Mechanism of action

Ambenonium chloride works by inhibiting acetylcholinesterase, an enzyme that breaks down acetylcholine in the body. By inhibiting this enzyme, ambenonium chloride increases the amount of acetylcholine available to stimulate muscle contractions, thereby improving muscle strength in people with myasthenia gravis.

Uses

Mytelase is used to treat the symptoms of myasthenia gravis, a neuromuscular disorder that causes weakness in the skeletal muscles. It can help improve muscle strength and reduce muscle fatigue in people with this condition.

Side effects

Common side effects of Mytelase include nausea, vomiting, diarrhea, and abdominal cramps. In rare cases, it can cause more serious side effects such as bronchospasm, bradycardia, and hypotension.

Contraindications

Mytelase should not be used in people with a known hypersensitivity to ambenonium chloride or any of the other ingredients in the medication. It is also contraindicated in people with mechanical obstruction of the intestinal or urinary tract.

Interactions

Mytelase can interact with other medications, including other cholinesterase inhibitors, anticholinergic drugs, and certain anesthetics. These interactions can increase the risk of side effects or reduce the effectiveness of the medication.

See also

• Myasthenia gravis
• Cholinesterase inhibitor
• Acetylcholine

Mytelase Resources
Latest articles Most recent articles Ongoing trials	Wikipedia